It looks like some strategists are buyiwng call options to get ahead of any potential rebound in the price of the underlying should selling pressure ease up ahead of October expiration.

FORBES: Options Players Speculate On Crocs Rebound, Count On Domino's To Go Flat

Patent expiration of cholesterol-lowering medicines Zocor and Pravachol will put particular pressure on Pfizer 's Lipitor as health plans push their enrollees to use the copycat drugs instead.

FORBES: Magazine Article

Patent expiration of cholesterol-lowering medicines Zocor and Pravachol will put particular pressure on Pfizer 's (nyse: PFE - news - people ) Lipitor as health plans push their enrollees to use the copycat drugs instead.

FORBES: Robert Langreth On Health Care